Peritoneal Surface Oncology Unit

Peritoneal Surface Oncology Unit

Peritoneal surface oncology is an upcoming branch of oncology, which is gradually gaining popularity across various sub-specialties of oncology, as it caters to advanced stage and widespread cancers.

In Thangam hospital a fully equipped and dedicated peritoneal surface oncology unit was started in 2018. Any patient of gastric cancer, ovarian cancer, colo-rectal cancer, endometrial cancer, pancreatic cancer or small bowel cancer in advanced stage or patients with pseudomyxoma peritonei, malignant mesothelioma or primary peritoneal serous carcinoma, after a thorough clinical and radiological evaluation are discussed in multi-disciplinary tumor board to decide the best possible and evidence based treatment plan.

All forms of treatment needed for managing these advanced cancers are available at our center:

  1. Cytoreductive surgery
  2. HIPEC (Hyperthermic Intraperitoneal chemotherapy)
  3. IP (Intraperitoneal chemotherapy) with IP port placement
  4. BISIC (Bi-directional intraperitoneal and systemic induction chemotherapy)
  5. PIPAC (Pressurized intraperitoneal aerosolized chemotherapy)
  6. HITOC (Hyperthermic intrathoracic chemotherapy)

There is a dedicated team comprising of surgical oncologists, medical oncologists, radiation oncologist, anaesthetists, intensivist, paramedics, nursing staff, physiotherapists, dietician, pain care specialist to cater to all the aspects involved in the treatment of these patients. Our aim is to provide wholesome care including psychological counseling of patients and relatives, including providing financial help with the help of our hospital trust.

Data of all these patients is maintained in prospective manner to help in future research further aiming to improvise treatment of these advanced stage cancers. Also, the department of peritoneal surface oncology is running several clinical trials with ethics committee approval which are investigator initiated.